Pharmaceutical Emulsions Industry Research Trends: Product Launches, FDA Approvals & Revenue Insights

Pharmaceutical Emulsions market size reached US$1.66Billion in 2024 from US$1.57Billionin 2023 and is expected to reach US$ 2.89Billion by 2033, growing at a CAGR of 6.4%during the forecast period 2025-2033.

DataM Intelligence unveils its latest report on the "Pharmaceutical Emulsions Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

FDA Approvals

Regulatory approvals are further driving market growth. For example, in May 2024, Baxter International Inc. received FDA approval to expand the use of Clinolipid (Lipid Injectable Emulsion) for pediatric patients, including preterm and term neonates. Clinolipid, Baxter's proprietary mixed-oil lipid emulsion, provides calories and essential fatty acids through parenteral (intravenous) nutrition when oral or enteral feeding is insufficient or not possible. Previously approved for adults in the U.S. since 2019, it is now available for patients of all ages.

In January 2025, Glenmark Pharmaceuticals USA launched Phytonadione Injectable Emulsion USP 10 mg/mL Single Dose Ampules, bioequivalent and therapeutically equivalent to Hospira's Vitamin K1 Injectable Emulsion USP 10 mg/mL.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/pharmaceutical-emulsions-market?kb

Key Market Highlights

North America leads the pharmaceutical emulsions market with a 42.17% revenue share in 2024.

Asia-Pacific is the fastest-growing region, projected to register a CAGR of 6.7% over the forecast period.

By route of administration, the injectable segment dominated with a 56.13% revenue share in 2024.

Leading players in the pharmaceutical emulsions market include Fresenius Kabi, Baxter, B. Braun SE, Pfizer Inc., Glenmark Pharmaceuticals, Amneal Pharmaceuticals, Grifols S.A., Kelun, and Guangdong Otsuka Pharmaceutical.

List of Top Key Player:

Fresenius Kabi, Baxter, B. Braun SE, Pfizer Inc., Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Grifols, S.A., Kelun, and Guangdong Otsuka Pharmaceutical Co., Ltd., among others.

Forecast Projection:

The Global Pharmaceutical Emulsions Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Pharmaceutical Emulsions Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-emulsions-market

Key Segmentation:

Injectable leads pharma emulsions, 56.13% share 2024

By Type: (Oil-in-Water (O/W), Water-in-Oil (W/O), and Mixed Emulsions)

By Route of Administration: (Oral, Injectable, Topical / External, Rectal / Vaginal, and Others)

By Application: (Oncology, Cardiovascular, Neurology, Anti-Infectives, Dermatology, and Others)

By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

FDA-approved lipid emulsions like SMOFlipid and Clinolipid highlight strong clinical adoption in the US, driving market growth. In April 2025, Avenacy launched Propofol Injectable Emulsion, USP, a generic equivalent to Diprivan, for anesthesia and ICU sedation across age groups. Leading players such as Fresenius Kabi, Baxter, and B. Braun are expanding in APAC with product launches and partnerships, making it the fastest-growing region globally.

In Europe, rising demand for parenteral nutrition and critical care fuels growth, supported by EMA-approved products like SMOFlipid and Clinolipid. Innovations in lipid-based drug delivery, including drug-loaded emulsions and lipid nanoparticles, enhance solubility, bioavailability, and targeted therapy, positioning Europe as a key driver in the global pharmaceutical emulsions market.

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Latest M&A

July-September 2025 saw major pharma consolidation, with deals such as Merck's $10 billion acquisition of Verona Pharma (July 2025), which expands access to specialized cardio-pulmonary products including advanced emulsions for respiratory care.

Specialty mergers like the pending $6.7 billion combination of Endo and Mallinckrodt are set to unify extensive portfolios in sterile injectables, including emulsion products for hospital and specialty markets.

Strategic asset purchases (e.g., Destiny Pharma's transaction, September 2025) indicate growing interest in novel drug delivery systems, including emulsions, in oncology and infectious disease pipelines.

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Pharmaceutical Emulsions Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pharmaceutical-emulsions-market?kb

FAQ's

Q1: How fast is the Pharmaceutical Emulsions Market expected to grow in the coming years?

A: The market is forecast to expand at a robust CAGR of 6.4% between 2025 and 2032, signaling strong global growth and investment potential.

Q2: Which regions are dominating the Pharmaceutical Emulsions Market and which are fastest-growing?

A: North America leads with 42.17% share, Asia-Pacific fastest-growing at 6.7% CAGR.

Q3: What factors are fueling the Pharmaceutical Emulsions Market's growth across regions?

A: Growth is propelled by increasing demand, strategic initiatives by key players, and untapped opportunities in emerging markets, helping companies maximize revenue potential.

Latest Product Launches & Developments

Avenacy launched Propofol Injectable Emulsion, USP (April 2025) as a therapeutic generic equivalent of Diprivan®, supporting anesthesia and sedation in ICU/adult patients in the United States.

Glenmark Pharmaceuticals and Alembic Pharmaceuticals received US FDA approval for Phytonadione Injectable Emulsion (Vitamin K1 Emulsion; September 2025), expanding options for emergency and critical care.

Upsher-Smith added Difluprednate Ophthalmic Emulsion to its generics line in September 2025, increasing access to steroid eye treatments for inflammation and recovery.

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.